FDA details challenges, research gaps in regulating cannabis-derived products

Federal food and drug regulators this week highlighted the challenges they’re facing in regulating CBD and other cannabis-derived products, and the knowledge gaps that still exist due to a continued lack of data regarding the science of CBD and other cannabinoids.

FDA details challenges, research gaps in regulating cannabis-derived products is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

>